| # | Drug | Count |
|---|---|---|
| 0 | EFAVIRENZ | 8 |
| 1 | LAMIVUDINE | 8 |
| 2 | LAMIVUDINE ORAL | 8 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE | 5 |
| 4 | ABACAVIR AND LAMIVUDINE | 3 |
| 5 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 3 |
| 6 | RITONAVIR | 3 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 3 |
| 8 | DARUNAVIR | 2 |
| 9 | EMTRICITABINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ABACAVIR AND LAMIVUDINE | 3 | 0.0150 |
| 1 | EFAVIRENZ | 8 | 0.0007 |
| 2 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 3 | 0.0005 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 3 | 0.0003 |
| 4 | LAMIVUDINE | 8 | 0.0003 |
| 5 | ZIDOVUDINE | 2 | 0.0002 |
| 6 | CLOFAZIMINE | 1 | 0.0002 |
| 7 | RILPIVIRINE | 1 | 0.0001 |
| 8 | DARUNAVIR | 2 | 0.0001 |
| 9 | NEVIRAPINE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0004 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 14 | 0.0003 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 16 | 0.0001 |
| 3 | Protease Inhibitor [EPC] | 3 | 0.0001 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 3 | 0.0000 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 6 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 7 | Fluoroquinolone Antibacterial [EPC] | 1 | 0.0000 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Proton Pump Inhibitor [EPC] | 1 | 0.0000 |